Core Laboratories (CLB) PT Lowered to $47 at RBC Capital

January 9, 2020 2:31 PM EST Send to a Friend
RBC Capital analyst Kurt Hallead lowered the price target on Core Laboratories (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login